• J&J faces $2bn insurance fraud charges over opioid claims pharmaceutical-technology
    September 21, 2020
    The New York State Department of Financial Services (DFS) has filed a $2bn lawsuit against Johnson & Johnson (J&J) for its alleged role in the opioid crisis in the US.
  • Health Highlights drugs
    May 08, 2019
  • FDA rejects Mallinckrodt’s abuse-deterrent form of Roxicodone pharmatimes
    December 13, 2018
  • Lannett Receives FDA Approval for Oxycodone, Acetaminophen Tablets americanpharmaceuticacreview
    September 28, 2017
    Our planned product launches, combined with our on-going integration and cost reduction efforts, are just some of the factors that give us confidence Lannett's future is bright."
PharmaSources Customer Service